UNITED KINGDOM – GSK and Oxford have launched a five-year collaboration aimed at accelerating R&D breakthroughs in a variety of difficult-to-treat diseases such as Alzheimer’s and Parkinson’s through the use…
Read MoreGSK takes aim at CNS diseases with University of Oxford partnership
